ESOPJul 2, 2026, 04:07 PM
Spyre Grants 58,843 Stock Options & 2,134 RSUs to New Employees
AI Summary
Spyre Therapeutics, Inc. announced that its Compensation Committee approved the grant of equity inducement awards to six new non-executive employees. These awards include 58,843 stock options and 2,134 restricted stock units (RSUs) under the 2018 Equity Inducement Plan. The grants were material to the employees' acceptance of employment and are subject to specific vesting schedules and continuous service.
Key Highlights
- Granted 58,843 stock options to six non-executive employees.
- Granted 2,134 restricted stock units (RSUs) to six non-executive employees.
- Stock options have an exercise price of $88.89, based on July 1, 2026 closing price.
- Stock options vest 25% on first anniversary, then 1/48th monthly thereafter.
- RSUs vest 25% on each anniversary of the next February 15, May 15, August 15, or November 15.
Price Impact
More from SYRE